Paper Presentation: Symptoms Across the Cancer Continuum—Symptoms and Quality of Life of Children and Adolescents Receiving Cellular Therapies (209-2)

3:50 – 4:10 pm Wednesday, September 2

Hematopoietic stem cell transplantation (HSCT) and chimeric antigen receptor (CAR) T-cell therapy are potentially curative therapies for children with life-threatening conditions but can result in a high symptom burden and poor quality of life (QoL).

This session will review the results of a multisite study that prospectively evaluated the impact of parent psychological distress on symptoms and quality of life experienced by children undergoing transplantation or cellular therapy. Clinical implications such as routine, comprehensive symptom assessment with the novel, multimodal interventions, and increased psychoeducational support tailored to address parental distress will be discussed.

Jessica Ward, PhD MPH CPNP RN
CNE Hours: